37 related articles for article (PubMed ID: 23902929)
1. Binding free energies for nicotine analogs inhibiting cytochrome P450 2A6 by a combined use of molecular dynamics simulations and QM/MM-PBSA calculations.
Lu H; Huang X; AbdulHameed MD; Zhan CG
Bioorg Med Chem; 2014 Apr; 22(7):2149-56. PubMed ID: 24631364
[TBL] [Abstract][Full Text] [Related]
2. Structure-Function Studies of Naphthalene, Phenanthrene, Biphenyl, and Their Derivatives in Interaction with and Oxidation by Cytochromes P450 2A13 and 2A6.
Shimada T; Takenaka S; Kakimoto K; Murayama N; Lim YR; Kim D; Foroozesh MK; Yamazaki H; Guengerich FP; Komori M
Chem Res Toxicol; 2016 Jun; 29(6):1029-40. PubMed ID: 27137136
[TBL] [Abstract][Full Text] [Related]
3. Structural and thermodynamic basis of (+)-α-pinene binding to human cytochrome P450 2B6.
Wilderman PR; Shah MB; Jang HH; Stout CD; Halpert JR
J Am Chem Soc; 2013 Jul; 135(28):10433-40. PubMed ID: 23786449
[TBL] [Abstract][Full Text] [Related]
4. Identification of New Substrates and Inhibitors of Human CYP2A7.
Ashraf RA; Liu S; Wolf CA; Wolber G; Bureik M
Molecules; 2024 May; 29(10):. PubMed ID: 38792050
[TBL] [Abstract][Full Text] [Related]
5. Structural and biophysical characterization of human cytochromes P450 2B6 and 2A6 bound to volatile hydrocarbons: analysis and comparison.
Shah MB; Wilderman PR; Liu J; Jang HH; Zhang Q; Stout CD; Halpert JR
Mol Pharmacol; 2015 Apr; 87(4):649-59. PubMed ID: 25585967
[TBL] [Abstract][Full Text] [Related]
6. Syntheses of arnottin I and arnottin II.
Moschitto MJ; Anthony DR; Lewis CA
J Org Chem; 2015 Mar; 80(6):3339-42. PubMed ID: 25748275
[TBL] [Abstract][Full Text] [Related]
7. Quantitative structure-activity relationship to elucidate human CYP2A6 inhibition by organosulfur compounds.
Ramirez DA; Marchevsky EJ; Luco JM; Camargo AB
ADMET DMPK; 2019; 7(3):196-209. PubMed ID: 35350661
[TBL] [Abstract][Full Text] [Related]
8.
Wu Q; Cai C; Guo P; Chen M; Wu X; Zhou J; Luo Y; Zou Y; Liu AL; Wang Q; Kuang Z; Fang J
Front Pharmacol; 2019; 10():458. PubMed ID: 31130860
[TBL] [Abstract][Full Text] [Related]
9. Coumarins and P450s, Studies Reported to-Date.
Foroozesh M; Sridhar J; Goyal N; Liu J
Molecules; 2019 Apr; 24(8):. PubMed ID: 31022888
[TBL] [Abstract][Full Text] [Related]
10. Hepatotoxicity of Herbal Supplements Mediated by Modulation of Cytochrome P450.
Brewer CT; Chen T
Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29117101
[TBL] [Abstract][Full Text] [Related]
11. Effects of methoxsalen, a CYP2A5/6 inhibitor, on nicotine dependence behaviors in mice.
Bagdas D; Muldoon PP; Zhu AZ; Tyndale RF; Damaj MI
Neuropharmacology; 2014 Oct; 85():67-72. PubMed ID: 24859605
[TBL] [Abstract][Full Text] [Related]
12. Structures of human microsomal cytochrome P450 2A6 complexed with coumarin and methoxsalen.
Yano JK; Hsu MH; Griffin KJ; Stout CD; Johnson EF
Nat Struct Mol Biol; 2005 Sep; 12(9):822-3. PubMed ID: 16086027
[TBL] [Abstract][Full Text] [Related]
13. (R)-(+)-Menthofuran is a potent, mechanism-based inactivator of human liver cytochrome P450 2A6.
Khojasteh-Bakht SC; Koenigs LL; Peter RM; Trager WF; Nelson SD
Drug Metab Dispos; 1998 Jul; 26(7):701-4. PubMed ID: 9660853
[TBL] [Abstract][Full Text] [Related]
14. Inhibition and inactivation of cytochrome P450 2A6 and cytochrome P450 2A13 by menthofuran, β-nicotyrine and menthol.
Kramlinger VM; von Weymarn LB; Murphy SE
Chem Biol Interact; 2012 May; 197(2-3):87-92. PubMed ID: 22486895
[TBL] [Abstract][Full Text] [Related]
15. CYP2A6: genetics, structure, regulation, and function.
Raunio H; Rahnasto-Rilla M
Drug Metabol Drug Interact; 2012 May; 27(2):73-88. PubMed ID: 22706231
[TBL] [Abstract][Full Text] [Related]
16. Structure, function, regulation and polymorphism of human cytochrome P450 2A6.
Di YM; Chow VD; Yang LP; Zhou SF
Curr Drug Metab; 2009 Sep; 10(7):754-80. PubMed ID: 19702528
[TBL] [Abstract][Full Text] [Related]
17. Synthetic models related to methoxalen and menthofuran-cytochrome P450 (CYP) 2A6 interactions. benzofuran and coumarin derivatives as potent and selective inhibitors of CYP2A6.
Yamaguchi Y; Akimoto I; Motegi K; Yoshimura T; Wada K; Nishizono N; Oda K
Chem Pharm Bull (Tokyo); 2013; 61(10):997-1001. PubMed ID: 23902929
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
